References
- Le Gassicke J, Ashcroft G, Eccleston D, Evans J, Oswald I, Ritson FB. The clinical state, sleep and amine metabolism of a tranylcypromine (Pernate) addict. Brit J Psychiat 1965; 111: 357–364
- Pennings E, Verkes R, Koning J, Jansen S, Vermeij P. Tranylcypromine intoxication with malignant hyperthermia, delirium and thrombocytopenia. J Clin Psychpharmacol 1997; 7: 430–431
- Chatterjee A, Tosyali M. Thrombocytopenia and delirium associated with tranylcypromine overdose. J Clin Psychpharmacol 1995; 15: 143–144
- Davids E, Röschke J, Klawe C, Gründer G, Schmoldt A. Tranylcypromine abuse associated with delirium and thrombocytopenia. J Clin Psychpharmacol 2000; 20: 270–271
- Szelenyi A, Albrecht J. Tranylcypromine abuse associated with an isolated thrombocytopenia. Pharmacopsychiat 1998; 31: 238–239
- Ben-Arie O, George G. A case of tranylcypromine (pernate) addiction. Brit J Psychiat 1979; 135: 273–274
- Biggs N, Jefferson J, Koenecke F. Tranylcypromine addiction: A case report and review. J Clin Psychiatry 1990; 51: 426–429
- Dilsaver S. Monomanino oxidase inhibitor withdrawal phenomenes: Symptoms and pathophysiology. Acta Psychiatr Scand 1993; 78: 1–8
- Brady K, Lydiard B, Kellner C. Tranylcypromine abuse. Am J Psychiatry 1991; 148: 1268–1269
- Griffin N, Draper R, Webb M. Addiction to tranylcypromine. Brit Med J 1981; 283: 346